Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05736146 · ClinicalTrials.gov registry record

Validating Gulf War Illness Blood Biomarkers

A clinical trial of Gulf War Illness and Gulf War Syndrome, sponsored by Roskamp Institute.

Recruiting
Registry status
100
Enrollment target
3
Study locations

NCT05736146 is a study of Gulf War Illness and Gulf War Syndrome that is actively recruiting participants, run by Roskamp Institute. The registered enrollment target is 100 participants, below the 123-participant average among 14 other Gulf War Illness trials with a reported enrollment target (19% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05736146, a study of Gulf War Illness and Gulf War Syndrome, is actively recruiting participants, sponsored by Roskamp Institute.

RECRUITING
Registry status
100 participants
Enrollment target
3
Study locations

Study Summary

The investigators goals are to identify blood lipids/metabolites that correlate with cognitive decline in the presence of the APOE ε4 allele among veterans with GWI. To determine the effect of dietary, medical and biological factors that influence lipid and metabolites in blood from GW veterans. To identify blood lipid/metabolite profiles that correlate with bioenergetics deficits and glial activation in the brains of GWI. To validate blood biomarker signatures of GWI using APOE genotyping and blood lipids/metabolites that correlate with the CNS dysfunction in GWI.

Study Locations (3)

California

  • Palto Alto Veterans Institute for Research - Palo Alto

Florida

  • The Roskamp Institute - Sarasota

Massachusetts

  • Boston University - Boston

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2022-06-30
Est. Completion 2026-03-01

Sponsor

Roskamp Institute

7 total trials

What the Registry Record Tells You About NCT05736146

The ClinicalTrials.gov registry entry for NCT05736146 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 123-participant average among 14 other Gulf War Illness trials with a reported enrollment target (19% lower). The listed sponsor is Roskamp Institute, which has 7 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Gulf War Illness appearing as the primary indexed condition, and to 0 interventions.

NCT05736146 reports 3 study locations spanning 3 distinct geographic areas - top geographies include California, Florida, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05736146 about?

NCT05736146 is a clinical study titled "Validating Gulf War Illness Blood Biomarkers". The investigators goals are to identify blood lipids/metabolites that correlate with cognitive decline in the presence of the APOE ε4 allele among veterans with GWI. To determine the effect of dietary, medical and biological factors that influence lipid and metabolites in blood from GW veterans. To ...

What is the current status of trial NCT05736146?

This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2022-06-30. Estimated completion is 2026-03-01.

What conditions does trial NCT05736146 study?

This clinical trial studies the following conditions: Gulf War Illness, Gulf War Syndrome.

Who is sponsoring clinical trial NCT05736146?

This trial is sponsored by Roskamp Institute, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05736146 being conducted?

This trial has 3 study locations across California, Florida, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Gulf War Illness

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.